SCHEMBL845519

SCHEMBL845519

O=C(Nc1ccc(/C=C/c2ccc(NC(=O)[C@@H]3CCCN3C(=O)CC3CC3)cc2)cc1)[C@@H]1CCCN1C(=O)CC1CC1

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
HTT P42858 2/20 0.46
NPC1 O15118 1/20 0.45
PABPC1 P11940 1/20 0.44
MAPK1 P28482 1/20 0.44
HCRTR1 O43613 2/20 0.43
HCRTR2 O43614 2/20 0.43
CNR1 P21554 1/20 0.43
CNR2 P34972 1/20 0.43
PREP P48147 2/20 0.43
F2 P00734 1/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
RHOC P08134 1/20 0.43
RHOA P61586 1/20 0.43
GAA P10253 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL845251 0.86 PABPC1 (0.50) ALDH1A1CYP2C9CYP2C19HTTNPC1
SCHEMBL15114690 0.85 PABPC1 (0.47) ALDH1A1CYP2C9CYP2C19HTTNPC1
SCHEMBL13272431 0.85 PABPC1 (0.39) ALDH1A1CYP2C9CYP2C19HTTNPC1
SCHEMBL845228 0.84 HCRTR1 (0.49) ALDH1A1CYP2C9CYP2C19HTTNPC1
SCHEMBL845521 0.84 ALDH1A1 (0.47) ALDH1A1CYP2C9CYP2C19HTTNPC1
SCHEMBL844899 0.84 NPC1 (0.52) ALDH1A1CYP2C9CYP2C19HTTNPC1
SCHEMBL845206 0.83 CYP2C9 (0.52) ALDH1A1CYP2C9CYP2C19HTTNPC1
SCHEMBL845245 0.83 PTPN1 (0.50) ALDH1A1CYP2C9CYP2C19HTTNPC1
SCHEMBL844902 0.83 ALDH1A1 (0.47) ALDH1A1CYP2C9CYP2C19HTTNPC1
SCHEMBL845027 0.83 ALDH1A1 (0.48) ALDH1A1CYP2C9CYP2C19NPC1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed